Supplemental material
Open access
78,772
Views
65
CrossRef citations to date
0
Altmetric
Research Article
Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens
Georgi Momekova Lab of Experimental Chemotherapy and Molecular Pharmacology, Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaCorrespondence[email protected]
https://orcid.org/0000-0003-2841-7089
& https://orcid.org/0000-0003-2841-7089
Denitsa Momekovab Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
Pages 469-474
|
Received 16 Apr 2020, Accepted 23 May 2020, Published online: 05 Jun 2020
Related Research Data
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Source:
Oxford University Press (OUP)
Potential antivirals and antiviral strategies against SARS coronavirus infections
Source:
Informa UK Limited
Ivermectin detection in serum of onchocerciasis patients: relationship to adverse reactions
Source:
American Society of Tropical Medicine and Hygiene
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Source:
Springer Science and Business Media LLC
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses.
Source:
Elsevier BV
Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects
Source:
Wiley
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Source:
Springer Science and Business Media LLC
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19.
Source:
Cold Spring Harbor Laboratory
The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer
Source:
Elsevier BV
Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
Source:
Springer Science and Business Media LLC
The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution.
Source:
Springer Science and Business Media LLC
Ivermectin levels in human breastmilk
Source:
Springer Science and Business Media LLC
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.